Literature DB >> 25701129

Functional outcomes of adjustable continence therapy (ACT™) balloons in women aged >80 years and suffering from stress urinary incontinence caused by intrinsic sphincter deficiency.

Claire Billault1, Emmanuel Chartier-Kastler1, Morgan Rouprêt1, Gilberte Robain2, Véronique Phé3.   

Abstract

OBJECTIVE: To determine the functional outcomes of adjustable continence therapy (ACT™) balloons in elderly women suffering from stress urinary incontinence (SUI) caused by intrinsic sphincter deficiency (ISD).
MATERIAL AND METHODS: A monocentric retrospective study included all non-neurological women aged >80 years who suffered from SUI due to ISD and undergoing ACT™ balloon placement between 2000 and 2013. Early post-operative complications were reported according to the Clavien-Dindo classification. Continence was assessed subjectively by the patients.
RESULTS: A total of 52 female patients were included, median age 83 years (IQR 81-85). Among them, 35 (67.3 %) had already undergone previous surgery for SUI. Balloon implantations were achieved under local anaesthesia for 33 (63.5 %) patients. Clavien grade I-II early post-operative complications occurred in five (9.6 %) patients. Median follow-up was 10.5 months (IQR 3-24.25). Eleven patients (21.1 %) were lost to follow-up. At last follow-up, seven patients (13.5 %) declared themselves fully continent after the first implantation, 13 patients (25 %) had an >80 % improvement rate (10 patients after first implantation, two after second implantation and one after third implantation). Four patients (7.7 %) found the procedure unsuccessful even after several consecutive implantations. Ten patients (19.2 %) reported a partial result and were still having successive balloon inflations. Explantation occurred in 22 patients, caused by infection, erosion or balloon migration. In intention-to-treat analysis, the failure rate was 42.3 %.
CONCLUSION: Although the success rate of ACT™ balloons in women aged >80 years is lower than that reported for younger women, it remains satisfactory because these patients would not otherwise have benefited from another surgical treatment.

Entities:  

Keywords:  Adjustable; Elderly; Sphincter deficiency; Stress; Urinary incontinence

Mesh:

Year:  2015        PMID: 25701129     DOI: 10.1007/s00345-015-1520-9

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  31 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

Review 2.  Stress incontinence injection therapy: what is best for our patients?

Authors:  Christopher R Chapple; Alan J Wein; Linda Brubaker; Roger Dmochowski; Montserrat Espuña Pons; François Haab; Simon Hill
Journal:  Eur Urol       Date:  2005-10       Impact factor: 20.096

3.  Body mass index does not influence the outcome of anti-incontinence surgery among women whereas menopausal status and ageing do: a randomised trial.

Authors:  Tomasz Rechberger; Konrad Futyma; Katarzyna Jankiewicz; Aneta Adamiak; Michał Bogusiewicz; Paweł Skorupski
Journal:  Int Urogynecol J       Date:  2010-02-24       Impact factor: 2.894

4.  Artificial urinary sphincter placement in elderly men.

Authors:  R Corey O'Connor; Dana K Nanigian; Bhavin N Patel; Michael L Guralnick; Lars M Ellision; Anthony R Stone
Journal:  Urology       Date:  2007-01       Impact factor: 2.649

5.  Epidemiology of stress urinary incontinence in women.

Authors:  W Stuart Reynolds; Roger R Dmochowski; David F Penson
Journal:  Curr Urol Rep       Date:  2011-10       Impact factor: 3.092

6.  Morbidity of incontinence surgery in women over 70 years old: a retrospective cohort study.

Authors:  Harriet Pugsley; Christopher Barbrook; Christopher J Mayne; Douglas G Tincello
Journal:  BJOG       Date:  2005-06       Impact factor: 6.531

7.  Treatment of moderate to severe female stress urinary incontinence with the adjustable continence therapy (ACT) device after failed surgical repair.

Authors:  Sherif R Aboseif; Pejvak Sassani; Ethan I Franke; Steven D Nash; Joel N Slutsky; Neil H Baum; Mai Le Tu; Niall T Galloway; Peter J Pommerville; Suzette E Sutherland
Journal:  World J Urol       Date:  2010-10-20       Impact factor: 4.226

Review 8.  Oestrogen therapy for urinary incontinence in post-menopausal women.

Authors:  June D Cody; Madeleine Louisa Jacobs; Karen Richardson; Birgit Moehrer; Andrew Hextall
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

9.  [French multicentre prospective study of the use of ACT balloons (Uromedica, Inc., Plymouth, Min, U.S.A.; Medtronic, Minneapolis, U.S.A.) for the treatment of female stress urinary incontinence].

Authors:  Emmanuel Chartier-Kastler; Pierre Costa; Kamel Ben Naoum; Florence Cour; Loïc Le Normand; François Haab
Journal:  Prog Urol       Date:  2007-11       Impact factor: 0.915

10.  Endoscopic collagen injection therapy in elderly women with type I stress urinary incontinence.

Authors:  G J Faerber
Journal:  J Urol       Date:  1996-02       Impact factor: 7.450

View more
  2 in total

1.  Effectiveness of the Remeex system™ in Colombian women with recurrent stress urinary incontinence or intrinsic sphincter deficiency.

Authors:  Mauricio Plata; Daniela Robledo; Alejandra Bravo-Balado; Juan Carlos Castaño; Catalina Osorio; Milton Salazar; Juan Guillermo Velásquez; Carlos Gustavo Trujillo; Juan Ignacio Caicedo; Juan Guillermo Cataño
Journal:  Int Urogynecol J       Date:  2018-03-03       Impact factor: 2.894

2.  A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle derived cells in female subjects with stress urinary incontinence.

Authors:  Ron J Jankowski; Le Mai Tu; Christopher Carlson; Magali Robert; Kevin Carlson; David Quinlan; Andreas Eisenhardt; Min Chen; Scott Snyder; Ryan Pruchnic; Michael Chancellor; Roger Dmochowski; Melissa R Kaufman; Lesley Carr
Journal:  Int Urol Nephrol       Date:  2018-10-15       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.